TrialHuman vaccines & immunotherapeutics2019

Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine compared to 13-valent pneumococcal conjugate vaccine in adults ≥65 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine.

James T Peterson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.